Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer

Resistance to TKI treatment is a major obstacle in effective treatment of NSCLC. Besides EGFR mutation status, the mechanisms involved are largely unknown. Some evidence supports a role for microRNA 21 in modulating drug sensitivity of chemotherapy but its role in NSCLC TKI resistance still remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Hua, Zhu, Fang, Liu, Jinyuan, Xu, Tongpeng, Pei, Dong, Wang, Rong, Qian, Yingying, Li, Qi, Wang, Lin, Shi, Zhumei, Zheng, Jitai, Chen, Qiudan, Jiang, Binghua, Shu, Yongqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110008/
https://www.ncbi.nlm.nih.gov/pubmed/25058005
http://dx.doi.org/10.1371/journal.pone.0103305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110008/
https://www.ncbi.nlm.nih.gov/pubmed/25058005
http://dx.doi.org/10.1371/journal.pone.0103305

Ejemplares similares